DURECT CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.33 EUR | -2.92% |
|
+9.92% | +153.33% |
| 05-21 | DURECT Corporation Receives FDA Breakthrough Therapy Designation for Larsucosterol in Alcohol-Associated Hepatitis | CI |
| 05-21 | Sector Update: Health Care Stocks Edge Higher Tuesday Afternoon | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DURECT CORPORATION | Bio Therapeutic Drugs | -2.92% | +9.92% | +153.33% | -73.92% | -79.74% | 47.18M | - | - | - |
Technical Rankings Surperformance
- Stock Market
- Equities
- DRRX Stock
- DC8A Stock
- Charts DURECT Corporation
- Comparison Chart
